---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-004708"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-07-09T23:59:59+00:00"
generated_at: "2026-05-31T22:37:38.411249+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals regains Nasdaq bid price compliance after 20-day period

## Summary
- Received Nasdaq deficiency letter Feb 27, 2024 for bid price below $1.00 for 30 consecutive days.
- On July 5, 2024, Nasdaq confirmed compliance as closing bid price ≥ $1.00 for 20 consecutive business days (June 5 – July 3, 2024).
- Matter is closed; company continues listing on Nasdaq Capital Market under ticker CNSP.

## SEC filing metadata
- accession: 0001683168-24-004708
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-07-09T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004708/0001683168-24-004708-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824004708/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-004708
- JSON: https://secwatch.observer/filing/0001683168-24-004708.json
- Plain text: https://secwatch.observer/filing/0001683168-24-004708.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.